 |
인쇄하기
취소
|
Pfizer Korea wins Lyrica patent infringement case
Published: 2013-05-24 06:59:00
Updated: 2013-05-24 06:59:00
The Seoul Central District Court ruled Wednesday that CJ Cheil Jedang had infringed on Pfizer’s Lyrica patent.
Lyrica, also known as Pregabalin, is used to treat chronic pain disorders like fibromyalgia and other neuropathic pain disorders.
CJ challenged the validity of the Lyrica patent and obtained a marketing license from the Ministry of Food and Drug Safety for its generic version of...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.